Effects of interleukin-15 on lipid oxidation Disposal of an oral [14C]-triolein load

被引:46
作者
Almendro, V [1 ]
Busquets, S [1 ]
Arrieffler, E [1 ]
Carbó, N [1 ]
Figueras, M [1 ]
Fuster, G [1 ]
Argilés, JM [1 ]
López-Soriano, FJ [1 ]
机构
[1] Univ Barcelona, Fac Biol, Canc Res Grp, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2006年 / 1761卷 / 01期
关键词
IL-15; lipid metabolism; skeletal muscle; liver; PPAR;
D O I
10.1016/j.bbalip.2005.12.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin 15 (IL-15) has previously been shown to have important effects on lipid metabolism in adipose tissue, particularly influencing the rate of the de novo fatty acid synthesis. The results presented here show that chronic administration to rats (100 mu g/kg body weight) has important effects on the metabolic fate of an exogenous [C-14]-triolein load, decreasing the incorporation of lipid into adipose tissue and significantly increasing the total (CO2)-C-14 formation from [C-14]-triolein. Skeletal muscle and possibly liver seem to be the main organs involved in the action of IL-15 on lipid oxidation, since the presence of the cytokine in incubated EDL muscle with [C-14]-palmitic acid increased (CO2)-C-14 formation by 39%. Concerning the mechanism, the results Suggest that the transport of fatty acids into mitochondria could be involved in the action of IL-15 since the cytokine clearly increases the presence of L-CPT-I and CPT-II in liver tissue. In addition, IL-15 treatment resulted in a significant increment in the gene expression of PPAR delta, a transcription factor clearly related with lipid catabolism in many tissues. Altogether, the results presented here suggest that IL-15 alters exogenous lipid partitioning, limiting adipose tissue uptake and favouring oxidation. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:37 / 42
页数:6
相关论文
共 25 条
[11]  
DONASCIMENTO CMO, 1986, BIOCHEM J, V239, P233
[12]  
EGGSTEIN M, 1974, METHOD ENZYMAT AN, P1825
[13]   Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: Modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15 [J].
Girard, D ;
Paquet, ME ;
Paquin, R ;
Beaulieu, AD .
BLOOD, 1996, 88 (08) :3176-3184
[14]   UTILIZATION OF THE BETA-CHAIN AND GAMMA-CHAIN OF THE IL-2 RECEPTOR BY THE NOVEL CYTOKINE-IL-15 [J].
GIRI, JG ;
AHDIEH, M ;
EISENMAN, J ;
SHANEBECK, K ;
GRABSTEIN, K ;
KUMAKI, S ;
NAMEN, A ;
PARK, LS ;
COSMAN, D ;
ANDERSON, D .
EMBO JOURNAL, 1994, 13 (12) :2822-2830
[15]   CLONING OF A T-CELL GROWTH-FACTOR THAT INTERACTS WITH THE BETA-CHAIN OF THE INTERLEUKIN-2 RECEPTOR [J].
GRABSTEIN, KH ;
EISENMAN, J ;
SHANEBECK, K ;
RAUCH, C ;
SRINIVASAN, S ;
FUNG, V ;
BEERS, C ;
RICHARDSON, J ;
SCHOENBORN, MA ;
AHDIEH, M ;
JOHNSON, L ;
ALDERSON, MR ;
WATSON, JD ;
ANDERSON, DM ;
GIRI, JG .
SCIENCE, 1994, 264 (5161) :965-968
[16]   Nutritional regulation and role of peroxisome proliferator-activated receptor δ in fatty acid catabolism in skeletal muscle [J].
Holst, D ;
Luquet, S ;
Nogueira, V ;
Kristiansen, K ;
Leverve, X ;
Grimaldi, PA .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2003, 1633 (01) :43-50
[17]   Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors [J].
Lee, CH ;
Olson, P ;
Evans, RM .
ENDOCRINOLOGY, 2003, 144 (06) :2201-2207
[18]  
López-Soriano J, 2004, INT J MOL MED, V13, P817
[19]   Peroxisome proliferator-activated receptor δ controls muscle development and oxydative capability [J].
Luquet, S ;
Lopez-Soriano, J ;
Holst, D ;
Fredenrich, A ;
Melki, J ;
Rassoulzadegan, M ;
Grimaldi, PA .
FASEB JOURNAL, 2003, 17 (13) :2299-+
[20]   Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPAR alpha and PPAR gamma activators [J].
Martin, G ;
Schoonjans, K ;
Lefebvre, AM ;
Staels, B ;
Auwerx, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (45) :28210-28217